Faller
Bernard Faller, Obermorschwiller FR
Patent application number | Description | Published |
---|---|---|
20090305995 | AGONISTS AND ANTAGONISTS OF THE SOMATOSTATIN RECEPTOR - The invention relates to substituted F3-Phe-trp-F 3-Lys-beta-tri-peptides and derivatives thereof, a process for their preparation, pharmaceutical preparations which contain these compounds which are agonists/antagonists of somatostatin receptors, as active agents for the treatment of disorders which can be influenced by a modulation of somatostatin receptor activity, in particular somatostatin receptor sst4 activity, by the compounds of the invention. | 12-10-2009 |
Christoph Faller, Greifensee CH
Patent application number | Description | Published |
---|---|---|
20160134989 | METHOD AND SIGNAL PROCESSING UNIT FOR MAPPING A PLURALITY OF INPUT CHANNELS OF AN INPUT CHANNEL CONFIGURATION TO OUTPUT CHANNELS OF AN OUTPUT CHANNEL CONFIGURATION - A method for mapping a plurality of input channels of an input channel configuration to output channels of an output channel configuration includes providing a set of rules associated with each input channel of the plurality of input channels, wherein the rules define different mappings between the associated input channel and a set of output channels. For each input channel of the plurality of input channels, a rule associated with the input channel is accessed, determination is made whether the set of output channels defined in the accessed rule is present in the output channel configuration, and the accessed rule is selected if the set of output channels defined in the accessed rule is present in the output channel configuration. The input channels are mapped to the output channels according to the selected rule. | 05-12-2016 |
20160142853 | APPARATUS AND METHOD FOR MAPPING FIRST AND SECOND INPUT CHANNELS TO AT LEAST ONE OUTPUT CHANNEL - An apparatus for mapping a first input channel and a second input channel of an input channel configuration to at least one output channel of an output channel configuration, wherein each input channel and each output channel has a direction in which an associated loudspeaker is located relative to a central listener position, configured to map the first input channel to a first output channel of the output channel configuration; and despite of the fact that an angle deviation between a direction of the second input channel and a direction of the first output channel is less than an angle deviation between a direction of the second input channel and the second output channel and/or is less than an angle deviation between the direction of the second input channel and the direction of the third output channel, map the second input channel to the second and third output channels by panning between the second and third output channels. | 05-19-2016 |
Frank Faller, Calgary CA
Patent application number | Description | Published |
---|---|---|
20130216356 | APPARATUS FOR EXTRACTING ENERGY FROM A FLUID FLOW - An apparatus for extracting energy from a fluid flow including a secondary fluid channel, a fluid driveable generator unit and a primary fluid channel. The primary fluid channel comprises a fluid intake in fluid communication with a throat. The throat is configured to increase the flow velocity and reduce the pressure of the primary fluid flowing through the primary fluid channel and includes at least one plenum in the interior of the throat configured to further reduce the pressure of the primary fluid flowing through the primary fluid channel. The plenum includes at least one perforation through its exterior surface in fluid communication with the secondary fluid channel. As such, the flow of primary fluid through the primary fluid channel draws the secondary fluid into the primary fluid channel through the secondary fluid channel and the perforation and thereby into driving engagement with the generator. | 08-22-2013 |
Marc Faller, Hegenheim FR
Patent application number | Description | Published |
---|---|---|
20110288251 | POLYMERISATION INITIATOR - The invention relates to novel O-dialkylamino-isoureas and polymerizable compositions comprising these O-dialkylamino-isoureas of compounds of the general formula (I). The invention further relates to the use of O-dialkylamino-isoureas as polymerization initiators, especially to prepare coatings or for controlled degradation of polyolefins. | 11-24-2011 |
20120041093 | POLYMERIZABLE COMPOSITIONS - The invention relates to the use of triazenes of formula (I) wherein Q is a direct bond or a bivalent radical —(CR | 02-16-2012 |
20120108696 | O-IMINO-ISO-UREA COMPOUNDS AND POLYMERIZABLE COMPOSITIONS THEREOF - The invention relates to the use of O-imino-iso-urea compounds as source of radicals to polymerizable compositions comprising these O-imino-iso-urea and to new O-imino-iso-urea compounds. The O-lmino-isoureas compounds are compounds of the Formula (I), wherein n is 1, 2, 3 or 4, R | 05-03-2012 |
20140018461 | PHOTO-LATENT TITANIUM-OXO-CHELATE CATALYSTS - A titanium-oxo-chelate catalyst formulation, comprising: (i) at least one compound of the formula (I), wherein R | 01-16-2014 |
20140113987 | O-IMINO-ISO-UREA COMPOUNDS AND POLYMERIZABLE COMPOSITIONS THEREOF - The invention relates to the use of O-imino-iso-urea compounds as source of radicals to polymerizable compositions comprising these O-imino-iso-urea and to new O-imino-iso-urea compounds. The O-Imino-isoureas compounds are compounds of the formula (I) | 04-24-2014 |
20150284604 | IMINOXYTRIAZINES AS RADICAL GENERATORS - Iminoxytriazine compounds of the formula I | 10-08-2015 |
Thomas Faller, Reinach CH
Patent application number | Description | Published |
---|---|---|
20100234467 | METHODS FOR IMPROVING BIOAVAILABILITY OF A RENIN INHIBITOR - The present invention provides a method for improving the bioavailability of a renin inhibitor, preferably, of a ε-amino-γ-hydroxy-ω-aryl-alkanoic acid derivative, which method comprises co-administering to a mammal, especially a human, in need of such treatment, a combination of a renin inhibitor, or a pharmaceutically acceptable salt thereof, and an MDR | 09-16-2010 |
Torbjoern Faller, Skedsmokorset NO
Patent application number | Description | Published |
---|---|---|
20150319603 | METHOD FOR SERVING VISITOR SUBSCRIBERS IN A MOBILE COMMUNICATION SYSTEM - A method for serving visitor subscribers in a mobile communication system has been disclosed. The method, which is performed by a virtual visitor subsystem, VSS, included in the mobile communication system, comprises the following steps: detecting a roaming event on an MSISDN of a mobile station, MS, operating in the mobile communication system; determining a mobile network operator in the mobile communication system, having an HPLMN which covers a geographic area of the MS, to be a visitor mobile network operator of the MS; receiving a visitor IMSI from the visitor mobile network operator; assigning the visitor IMSI to the MSISDN of the MS; transmitting the visitor IMSI to the MS; intercepting an authentication initiation towards the visitor mobile network operator; authenticating the MS towards a home mobile network operator of the MS; and activating a visitor subscription identified by the visitor IMSI based on an authentication response received from the home mobile network operator. | 11-05-2015 |
William Faller, Dublin IE
Patent application number | Description | Published |
---|---|---|
20090093424 | Markers for melanoma - A method of diagnosing melanoma and/or monitoring melanoma progression, in particular for determining whether the melanoma is likely to have metastatic capabilities, in a subject includes the steps of in a test sample determining the methylation status of FABP5 wherein methylation of the gene indicates a positive diagnosis of melanoma and/or increased methylation of the gene indicates the progression of melanoma. Methods of monitoring melanoma progression may also incorporate measuring the expression levels of FABP5, with low levels of expression indicating a positive diagnosis of melanoma and/or lower levels of expression being indicative of progression of melanoma. Methods of treating melanoma in a subject comprise administering a therapeutically effective amount of a DNA methyltransferase inhibitor or a histone deacetylase inhibitor to the subject such that expression of FABP5 is increased. Microarrays for use in these diagnostic methods and compound screening methods based around monitoring methylation and/or expression of FABP5 are also envisaged. | 04-09-2009 |